SCHEMBL25756683

SCHEMBL25756683

C#CCCOCCCN[C@H]1CC[C@@H](N=[N+]=[N-])CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25784935 1.00
SCHEMBL25785385 0.93 SMN1; SMN2 (0.31)
SCHEMBL25756692 0.93 SMN1; SMN2 (0.31)
SCHEMBL25032292 0.92 SMN1; SMN2 (0.33)
SCHEMBL25756677 0.89 SMN1; SMN2 (0.30)
SCHEMBL25784799 0.89 SMN1; SMN2 (0.30)
SCHEMBL25756695 0.88 TSHR (0.31)
SCHEMBL25785503 0.88 TSHR (0.31)
SCHEMBL25773279 0.87
SCHEMBL25756106 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230210999-A1 TARGETED PROTEASE DEGRADATION (TED) PLATFORM EUBULUS BIOTHERAPEUTICS (HONG KONG) LIMITED (HK) 2023-07-06 US disclosed